Previous Article | Next Article 
Journal of Virology, June 2000, p. 5629-5638, Vol. 74, No. 12
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Human Cytomegalovirus Replicates Abortively in Polymorphonuclear
Leukocytes after Transfer from Infected Endothelial Cells via
Transient Microfusion Events
Giuseppe
Gerna,1,*
Elena
Percivalle,1
Fausto
Baldanti,1,2
Silvano
Sozzani,3
Paolo
Lanzarini,4
Emilia
Genini,1
Daniele
Lilleri,1 and
Maria Grazia
Revello1
Servizio di
Virologia,1 Laboratori Sperimentali di
Ricerca, Area Infettivologica,2 and
Istituto di Malattie Infettive,4
Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San
Matteo, 27100 Pavia, and Istituto di Ricerche
Farmacologiche Mario Negri, 20157 Milano,3 Italy
Received 18 November 1999/Accepted 22 March 2000
 |
ABSTRACT |
Using a recently developed model for in vitro generation of
pp65-positive polymorphonuclear leukocytes (PMNLs), we demonstrated that PMNLs from immunocompetent subjects may harbor both infectious human cytomegalovirus (HCMV) and viral products (pp65, p72, DNA, and immediate-early [IE] and pp67 late mRNAs) as early as 60 min after coculture with human umbilical vein endothelial cells (HUVEC) or
human embryonic lung fibroblasts (HELF) infected with a clinical HCMV
isolate (VR6110) or other wild-type strains. The number of PMNLs
positive for each viral parameter increased with coculture time. Using
HELF infected with laboratory-adapted HCMV strains, only very small
amounts of viral DNA and IE and late mRNAs were detected in PMNLs.
A cellular mRNA, the vascular cell adhesion molecule-1 mRNA,
which is abundantly present in both infected and uninfected HUVEC, was
detected in much larger amounts in PMNLs cocultured with
VR6110-infected cells than in controls. Coculture of PMNLs with
VR6110-infected permissive cells in the presence or absence of RNA,
protein, and viral DNA synthesis inhibitors showed that only IE genes
were transcribed in PMNLs during coculture. Synthesis of IE transcripts
in PMNLs was also supported by the finding that only the copy number of
IE mRNA (and not the DNA or the pp67 mRNA) per infected PMNL
increased markedly with time, and the pp67 to IE mRNA copy number
ratio changed from greater than 10 in infected HUVEC to less than 1 in
cocultured PMNLs. Fluorescent probe transfer experiments and electron
microscopy studies indicated that transfer of infectious virus and
viral products from infected cells to PMNLs is likely to be mediated by
microfusion events induced by wild-type strains only. In addition, HCMV
pp65 and p72 were both shown to localize in the nucleus of the same
PMNLs by double immunostaining. Two different mechanisms may explain
the virus presence in PMNLs: (i) one major mechanism consists of
transitory microfusion events (induced by wild-type strains only) of
HUVEC or HELF and PMNLs with transfer of viable virus and biologically
active viral material to PMNLs; and (ii) one minor mechanism, i.e.,
endocytosis, occurs with both wild-type and laboratory strains and
leads to the acquisition of very small amounts of viral nucleic acids.
In conclusion, HCMV replicates abortively in PMNLs, and wild-type
strains and their products (as well as cellular metabolites and
fluorescent dyes) are transferred to PMNLs, thus providing evidence for
a potential mechanism of HCMV dissemination in vivo.
 |
INTRODUCTION |
Diagnosis of disseminated
human cytomegalovirus (HCMV) infection in the immunocompromised host is
based on virus detection and quantitation in blood, namely in
peripheral blood polymorphonuclear leukocytes (PMNLs). Major diagnostic
assays using ex vivo PMNL preparations are HCMV viremia, i.e., recovery
of infectious virus from PMNLs (15); antigenemia, i.e.,
detection of HCMV pp65 in the nucleus of PMNLs (11, 14, 28,
34); leukoDNAemia, i.e., detection of viral DNA in PMNLs
(13); and leukoRNAemia, i.e., detection of viral mRNAs,
either immediate early (IE) (26, 35), late (1, 2, 12,
16, 17, 22, 25), or both (23, 24), in PMNLs. In
addition, the development of diagnostic assays showing the presence of
late mRNAs in PMNLs, besides that of IE mRNAs (10,
18) and infectious virus (12, 15), has strengthened the assumption that HCMV could productively replicate in PMNLs (3,
36). However, whether PMNLs are fully permissive for active
HCMV replication or may support only a partial
(abortive) virus replication or are passive carriers of virus or viral
material disseminating the infection into multiple body sites remains
to be determined. In addition, the mechanism underlying the
dissemination by PMNLs is obscure, since PMNLs should degrade viral
material uptaken by endocytosis.
In the present study, using a recently developed in vitro model for
generation of pp65-positive PMNLs (27), we showed that virus
and viral (as well as cellular) material detected in PMNLs are
transferred from permissive infected cells (either endothelial or human
fibroblasts) to PMNLs from immunocompetent individuals, while only
abortive virus replication occurs in PMNLs. The phenomenon is
mediated by microfusion events of infected cells and PMNLs, which occur
only when infection is sustained by wild-type and not
laboratory-adapted strains of HCMV. This mechanism has also been
investigated by fusion assays using fluorescent probes and by
electron microscopy (EM). Endocytosis, occurring with both wild-type
and adapted strains, appears to play a minor role.
 |
MATERIALS AND METHODS |
Cell cultures and virus strains.
Human umbilical vein
endothelial cells (HUVEC) were obtained by trypsin treatment of
umbilical cord veins and were used at passages three to six, as
previously reported (27). Human embryonic lung fibroblasts
(HELF) were derived from a cell strain originally developed in our
laboratory and used at passages 20 to 30. HCMV strains AD169, Towne,
and Davis (American Type Culture Collection, Rockville, Md.) were
routinely propagated in HELF cultures. A clinical strain (VR6110)
isolated from the blood of an AIDS patient was adapted to growth on
HUVEC, while it was propagated in parallel in HELF, as reported
(27). In addition, 50 clinical isolates recovered from
multiple body sites of both immunocompetent and immunocompromised
individuals were propagated in HELF and tested for pp65 antigen in
PMNLs following coculture.
Coculture of PMNLs and HCMV-infected cell cultures.
Concentrated PMNL preparations (degree of purity, >95%) were obtained
from blood donors as reported (11, 27) and were routinely
tested by nested PCR (13) and found to be negative for viral
DNA. Then, PMNLs were cocultured with HUVEC or HELF infected with
either wild-type or laboratory-adapted HCMV strains. In parallel, PMNL
preparations were cocultured with uninfected HUVEC. PMNLs were used
either on the day of collection or following overnight maintenance on
uninfected HUVEC monolayers. Unless otherwise indicated, HCMV-infected
cell cultures were used for coculture 96 h postinfection (p.i.).
Coculture time ranged from 1 to 24 h. Following coculture, to
separate PMNLs from infected HUVEC or HELF, cell mixtures were placed
in the upper compartment of a cell culture insert of 6.5-mm diameter
and 5-µm pore size (Transwell; Costar, Cambrige, Mass.) for 3 h
at 37°C in a 5% CO2 humidified atmosphere, while the
bottom compartment contained 10
8 M
formyl-methionyl-leucyl-phenylalanine (Sigma, St. Louis, Mo.), as
previously reported (11, 27).
FACS purification.
Migrated PMNLs were tested by different
viral assays before and after fluorescence-activated cell sorting
(FACS) purification following PMNL staining with CD66b (Immunotech,
Instrumentation Laboratory, Milan, Italy). Cell sorting was performed
with a FACStar PLUS apparatus (Becton Dickinson, Mountain View,
Calif.). Laser output was 240 mW at 488 nm. Sorting was carried out
according to standard FACStar specifications with a 3-drop deflection
criterion using a 70-µm-diameter nozzle. In addition, some PMNL
preparations were treated with 0.25% trypsin (GIBCO BRL, Paisley,
Scotland) solution at 37°C for 10 min prior to and after cell sorting.
Interference of endocytosis with results of viral assays.
The following sets of experiments were carried out as follows: PMNLs
were incubated for 3 h with Towne- or VR6110-infected HELF medium
and PMNLs were cocultured for 3 h with Towne- or VR6110-infected HELF. These conditions allowed the determination of the amount of viral
material taken up by endocytosis compared to the overall viral load of
PMNLs following coculture with either wild-type or laboratory HCMV
strain-infected HELF.
PMNL coculture and migration in the presence of mRNA,
protein, and viral DNA synthesis inhibitors.
In experiments
designed to investigate HCMV replication in PMNLs, these cells were
cocultured for 3 h with VR6110-infected HUVEC in the presence of
10 µg of actinomycin D (Sigma) per ml, 100 µg of cycloheximide
(Sigma) per ml, or 400 µM phosphonoformic acid (PFA) (Sigma).
Inhibitors were maintained at the same concentration during the 3 h migration step.
HCMV load in VR6110-infected HUVEC and in cocultured PMNLs.
The copy number of viral DNA, IE mRNA, and pp67 mRNA per
infected cell was determined in HUVEC at 96 h p.i. To determine
the number of PMNLs positive for DNA or mRNAs, serial PMNL mixtures containing a progressively decreasing number of cocultured PMNLs in a
progressively increasing number of PMNLs from healthy donors were
prepared and then tested in 105 aliquots. In parallel,
aliquots of 105 cocultured and unmixed PMNLs were tested by
different assays for the total amount of viral nucleic acids. Then, the
copy number of viral DNA, IE mRNA, and pp67 mRNA per infected
PMNL was calculated by dividing the total copy number for each viral
nucleic acid per 105 PMNLs by the number of PMNLs positive
for each parameter. In addition, the number of p72- and pp65-positive
PMNLs and the number of PMNLs carrying infectious virus was determined
according to well-standardized procedures (see below).
Viral assays.
The number of pp65- and p72-positive PMNLs was
determined on 105 PMNL cytospin preparations that were
fixed and stained according to a previously reported procedure
(11, 14). Quantification of infectious virus carried by
PMNLs following coculture was performed by inoculating 105
PMNLs onto HELF monolayers grown in shell vials and by counting the
number of HCMV p72-positive nuclei, which were stained 16 to 24 h
p.i. by using a monoclonal antibody to the HCMV major IE protein p72
(15). HCMV DNA was quantified in 105 PMNL
aliquots according to a reported quantitative PCR method by using a
primer pair relevant to exon 4 of the IE-1 gene (13). In a
set of experiments, viral DNA was quantified in parallel in cocultured
PMNLs and in isolated PMNL nuclei from the same cocultured preparations.
Nucleic-acid-sequence-based amplification (NASBA) for pp67 mRNA
determination (Nuclisens CMV pp67; Organon Teknika, Boxtel, The
Netherlands) was carried out following manufacturer's instructions. IE
mRNA was similarly determined by NASBA by using a qualitative experimental assay developed by the same manufacturer. Details of test
performance have been recently reported for NASBA pp67 mRNA
determination (2, 12). Briefly, 106 PMNLs were
added to 1.0 ml of NASBA lysis buffer, and the mixture was stored at
80°C. A standard amount of system control RNA, which served as an
internal positive control for the isolation, amplification, and
detection of RNA during the NASBA procedure, was added prior to nucleic
acid isolation. The nucleic acids were then eluted in 50 µl of 1.0 mM
Tris (pH 8.5) and were examined (5 µl/test, corresponding to
105 PMNL) or stored at
80°C. The NASBA reaction was
performed with a pair of primers designed to amplify a fragment of the
mRNA encoding HCMV pp67 (the UL65 late gene product) or a region of
the IE-1 transcript encoding HCMV p72. Following hybridization of the
amplification products with a specific capture and a specific
ruthenium-labeled detection probe, final reading of test results was
achieved by using an electrochemiluminescence instrument (NASBA QR
System; Organon Teknika). Semiquantification of IE and pp67 mRNA
was achieved by serial dilution of RNA extracts, taking into account
that the sensitivity of NASBA assay was 70 copies of input RNA of
either IE or pp67 mRNA (J. Middeldorp, Organon Teknika, personal
communication). A preliminary comparison of semiquantitative NASBA
results and quantitative determinations performed using a quantitative
NASBA assay now under evaluation showed that results obtained by the two methods were within 50% variations of the mean (data not shown).
Detection of VCAM-1 mRNA in HUVEC and PMNLs by RT-PCR.
A
new reverse transcriptase PCR (RT-PCR) technique for detection of the
two spliced forms of vascular cell adhesion molecule 1 (VCAM-1)
mRNA (7, 20) was developed. In detail, total RNA was
extracted from 6 × 106 aliquots of infected and
uninfected HUVEC as well as from 3 × 106 PMNLs
cocultured with infected and uninfected HUVEC by using the RNAzol B kit
(Tel-Test, Inc., Friendswood, Tex.) according to manufacturer's
instructions. Then, a region spanning domains 3, 4, and 5 of the VCAM-1
longer transcript as well as a region spanning domains 3 and 5 of the
VCAM-1 shorter transcript were retrotranscribed by using the antisense
primer R6 (5' AGC TTA CAG TGA CAG AGC TC 3', nucleotides [nt] 2275 to
2256) and were subsequently amplified by PCR by using primers F3 (5'
TCA CCT TAA TTG CTA TGA GG 3', nt 1685 to 1704) and R6. Reverse
transcriptase (RT) reaction was performed in a 20-µl total volume (15 pmol of R6 primer, 12 nmol of each deoxynucleoside triphosphate, 1×
PCR buffer, 200 U of Moloney murine leukemia virus RT) for 30 min at
37°C, using 106 and 105 aliquots of HUVEC and
PMNL, respectively. PCR was performed for 55 cycles (30 s at 94°C,
30 s at 55°C, and 45 s at 72°C) by adding 30 µl of PCR
mixture (1× PCR buffer, 25 pmol of F3 primer, 10 pmol of R6 primer,
2.5 U of Taq polymerase) to RT products. Finally, PCR
products were submitted to 20 additional cycles of amplification using
nested primers (F5, 5' GGA ATT TAT GTG TGT GAA GGA G 3', nt 1717 to
1738; R4, 5' ATC TCG ATT TCT GGA TCT C 3', nt 2233 to 2215). Predicted
sizes of nested RT-PCR products were 377 bp for the VCAM-1 longer
transcript and 99 bp for the shorter mRNA.
Blocking of HCMV transmission from PMNLs to uninfected HELF.
PMNL preparations cocultured with infected cell cultures were further
cultured, following migration, onto cell culture inserts of a
0.4-µm-pore-size membrane (Becton Dickinson), thus preventing the
contact of PMNLs with the underlying uninfected HELF cell monolayer. In
addition, prior to inoculation onto HELF cell cultures, in
vitro-generated HCMV-positive PMNLs were incubated overnight with
uninfected HELF in the presence or absence of either 6.9 µg of
anti-CD18 (DAKO, Glostrup, Denmark) per ml or 15.2 µg of anti-ICAM-1
(DAKO) monoclonal antibody per ml, or both. In parallel control
experiments, monoclonal antibodies anti-E-selectin, anti-ICAM-3, and
anti-PECAM-1 (R&D Systems, Inc., Minneapolis, Minn.) were tested at
their optimal concentrations.
Fusion assays.
To demonstrate fusion of VR6110-infected
HUVEC or HELF and PMNLs during coculture, two vital fluorescent dyes
were used: 5-chloromethylfluorescein diacetate (CMFDA) (Molecular
Probes, Eugene, Oreg.) and 5- and 6-([4-chloromethylbenzoyl)amino]tetramethylrhodamine (CMTMR,
Molecular Probes). Each dye was used as a 5 mM stock solution in
dimethylsulfoxide (Sigma). VR6110-infected and uninfected HUVEC (or
HELF) were stained with 10 µM CMFDA (Cell Tracker Green), whereas
PMNLs were stained with 1 µM CMTMR (Cell Tracker Orange) according to
a reported procedure (21). Microscopic observation of PMNLs
and their dual fluorescing fusion products was achieved by using a
fluorescent microscope (model DM RBE; Leica, Wetzlar, Germany) with
filter G/R 513803 (Leitz) designed for simultaneous excitation by
490 ± 20 and 575 ± 30 nm fluorescent light.
HCMV pp65 and p72 nuclear localization assays.
Initially,
the nuclear localization of HCMV pp65 and p72 was investigated by
double immunological staining of the same PMNL cytospin preparations,
which was performed as follows. First, following fixation with
paraformaldehyde and permeabilization (14), cells were
stained with a p72-specific monoclonal antibody (15) and an
anti-mouse immunoglobulin G fluorescein isothiocyanate (FITC)-labeled
conjugate (Cappel, Organon Teknika, West Chester, Pa.). Then the same
cell preparations were restained with guinea pig HCMV antiserum
prepared in the laboratory and previously shown to stain pp65 in PMNL
nuclei, followed by a secondary anti-guinea pig conjugate labeled with
either FITC or horseradish peroxidase (Cappel). Double staining with
two FITC-labeled conjugates was discriminating due to the markedly
different pattern of distribution of the two HCMV proteins inside PMNL
nuclei. Subsequently, PMNL preparations were double stained for
immunofluorescence laser confocal microscopy by simultaneous incubation
with the same two primary antibodies from mouse and guinea pig for 30 min and secondary anti-species antibodies labeled with FITC or
rhodamine (Cappel), respectively, for an additional 30 min. The samples
were examined with a PCM 2000 Confocal Microscope System (Nikon,
Melville, N.Y.) equipped with a Nikon Diaphot 300 inverted microscope
and a 40X (1.3 numerical aperture) Nikon oil fluorescence objective.
The 488-nm Argon laser line and the green He-Ne laser line were
directed to the sample with a single-mode fiber optic cable via
high-precision laser coupler. Pinhole size was set at 20 µm.
Fluorescence emission light was passed back through a first dichroic
mirror and was divided by a second dichroic mirror into light greater
or less than 565 nm. Green emission fluorescence of FITC continued
through a BA 515- to 530-nm-spectrum filter on CH1, and red emission
fluorescence of rhodamine was passed through a BA 590- to
660-nm-spectrum filter on CH2. The image size was set at 512 by 512 or
1,024 by 1,024 pixels.
EM study.
In vitro-generated HCMV-positive PMNLs and
HCMV-infected HUVEC or HELF were fixed with a mixture of two parts of
1% osmium tetroxide in 0.1 M cacodylate buffer and one part of 2.5%
glutaraldehyde in the same buffer. Fixed samples were resuspended in
saline solution and then were placed in 0.25% uranyl acetate for 30 min, dehydrated, and embedded in Epon 812. Ultrathin sections were
stained with uranyl acetate and lead citrate and were finally examined
with a Philips CM12 STEM electron microscope (Philips, Eindhoven, The Netherlands).
 |
RESULTS |
Kinetics of infectious virus and viral products in cocultured
PMNLs.
The kinetics of infectious virus and viral products in
PMNLs was investigated following 1-, 3-, and 24-h coculture times with VR6110-infected HUVEC. Results reported in Table
1 indicate that not only pp65, p72, and
IE mRNA, but also viral DNA, pp67 mRNA, and infectious virus
are detected in PMNLs after as little as 1 h of coculture with
VR6110-infected HUVEC at 96 h p.i. Thus, the presence in PMNLs of
late pp67 mRNA and infectious virus, at very early coculture times,
indicates uptake or transfer of viral material from permissive infected
HUVEC to PMNLs. Levels of viral DNA, pp65, and p72 as well as viral
mRNAs increased after 3 and 24 h of coculture, whereas the
levels of infectious virus decreased (Table 1). Following 3 h of
coculture, levels of viral DNA were distributed in comparable amounts
between nucleus and cytoplasm (data not shown). Examples of pp65
detection in PMNLs freshly collected or maintained in vitro overnight
prior to 3 h of coculture with infected HUVEC are given in Fig.
1A and B, respectively, while examples of
detection of p72 in PMNL nuclei following overnight in vitro
maintenance and 3 h of coculture with infected HUVEC are shown
below (see Fig. 5A and B).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
HCMV load in PMNLs after different coculture times with
VR6110-infected HUVEC and Towne-infected HELF at 96 h p.i.
|
|

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 1.
In vitro-generated pp65-positive PMNLs. (A) freshly
collected and cocultured for 3 h with HUVEC infected with VR6110
at 96 h p.i. and (B) cocultured for 3 h with infected HUVEC
at 96 h p.i., following overnight in vitro maintenance on HUVEC.
(A) Single pp65-positive PMNLs; (B) giant pp65-positive PMNLs.
|
|
Comparable results for pp65 antigen and infectious virus in PMNLs were
consistently obtained following coculture with HELF
infected with as
many as 50 clinical HCMV isolates, whereas pp65
antigen and recovery of
infectious virus were consistently negative
following coculture of
PMNLs with HELF infected with laboratory-adapted
HCMV
strains (Towne, AD169, and Davis) and levels of viral nucleic
acids were very low (Table
1).
Detection of VCAM-1 mRNA in HUVEC and PMNLs by RT-PCR.
In
both infected and uninfected HUVEC, longer and shorter VCAM-1 mRNAs
appeared to be expressed, with the longer form expressed at a higher
proportion. However, while both longer and shorter VCAM-1 mRNAs
were detected in aliquots of 106 and 105 PMNLs
cocultured for 24 h with infected HUVEC and the shorter form of
mRNA only in aliquots of 104 PMNLs, the longer
transcript could be detected only in aliquots of 106 PMNLs
cocultured with uninfected HUVEC, whereas the aliquots of
105 and 104 PMNLs were negative for both forms
of VCAM-1 transcripts (Fig. 2). Thus, the
shorter form was detected only in PMNLs cocultured with infected HUVEC.

View larger version (89K):
[in this window]
[in a new window]
|
FIG. 2.
Detection of VCAM-1 mRNAs in PMNLs and endothelial
cells by RT-PCR. The longer form (377-bp band) is detected in aliquots
of 106 and 105 PMNLs cocultured for 24 h
with infected HUVEC but is absent in aliquots of 104 and
105 PMNLs cocultured with uninfected HUVEC (control). The
shorter form (99-bp band) is detected only in aliquots of
106, 105, and 104 PMNLs cocultured
with infected HUVEC but is absent in aliquots of PMNLs cocultured with
uninfected HUVEC.
|
|
Virus and viral products detected in cocultured PMNLs are not
due to contaminating infected HUVEC or cell debris.
To verify
whether virus and viral products carried by cocultured PMNLs
could be due to contaminating HCMV-infected HUVEC or HUVEC debris,
preparations of PMNLs cocultured for 1 and 24 h were submitted to
FACS analysis after Transwell migration. In parallel, preparations of
migrated PMNLs obtained prior to and after FACS purification were
treated with trypsin. Results reported in Table
2 indicate that pp65 antigen and
infectious virus, as well as DNA, IE mRNA, and pp67 mRNA levels
did not change after trypsin treatment of 1-h-cocultured PMNLs or after
cell sorting. Substantially overlapping results were obtained by using
the same procedure on 24-h-cocultured PMNL preparations (data not
shown), thus confirming previously reported findings (27).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Effect of FACS purification and trypsin treatment on HCMV
load of PMNLs cocultured for 1 h with VR6110-infected HUVEC at
96 h p.i.
|
|
Contribution of endocytosis to HCMV load of cocultured PMNLs.
As reported in Table 3, following
incubation of PMNL preparations for 3 h with either Towne or
VR6110 cell-free virus suspensions or coculture with Towne-infected
HELF at 144 h p.i., pp65 and p72 antigen as well as infectious
virus were never detected, whereas DNA as well as IE and pp67 mRNAs
were weakly positive in PMNLs as compared to coculture with
VR6110-infected HELF at 144 h p.i. Based on these results, it was
concluded that a minor part of viral material carried by PMNLs after
cocultivation might be represented by nucleic acids uptaken by
endocytosis.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
HCMV load of PMNLs incubated for 3 h with Towne or
VR6110 cell-free virus suspensions and with Towne- or
VR6110-infected HELF: role of endocytosis
|
|
Effect of inhibitors on viral load of PMNLs.
When PMNLs were
both cocultured for 3 h with VR6110-infected HUVEC at 96 h
p.i. and migrated in the presence of actinomycin D, IE mRNA was
reduced by 99% in PMNLs, whereas the levels of pp67 mRNA did not
change significantly as well as the other virologic parameters (Fig.
3), indicating that IE mRNA synthesis
apparently occurs in PMNLs during coculture. On the other hand, levels
of pp65 and p72 antigens, DNA, IE mRNA, and pp67 mRNA in the
presence or absence of cycloheximide and PFA were comparable within a
3-h coculture time, except for an increase in IE mRNA in the
presence of cycloheximide with respect to controls. Infectious virus
was not recovered from PMNLs in the presence of actinomycin D and was
drastically reduced in titer or was absent in the presence of
cycloheximide, whereas it was not affected by PFA. Apparently, this
effect was not due to carryover of the inhibitor as shown by comparable
recovery of infectious virus from cocultured PMNL preparations either
mixed or not mixed with actinomycin D-treated PMNLs. Virus recovery was
also abolished if cocultured PMNLs were treated with actinomycin D for
1 h either prior to or after coculture, whereas it was not
affected by cycloheximide in the same experimental conditions (data not
shown). Only reduction of actinomycin D concentration from 10 to 1 µg/ml and reduction of treatment duration (30 min) allowed reversion
of the inhibitory effect on infectious virus recovery.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
HCMV load in PMNLs cocultured for 3 h with
VR6110-infected HUVEC at 96 h p.i. in the presence of actinomycin
D, cycloheximide, and phosphonoformic acid. Results are expressed as
percent values in the presence of inhibitors with respect to control
values obtained in the absence of inhibitors. pp65Ag, pp65 antigen;
p72Ag, p72 antigen; Vir, infectious virus.
|
|
HCMV load in VR6110-infected HUVEC and in PMNLs after coculture
with infected HUVEC.
The approximate copy numbers of viral DNA and
pp67 mRNA per infected cell were in the same order of magnitude in
infected HUVEC at 96 h p.i., whereas that of IE mRNA was more
than 10 times lower. The number of PMNLs positive for each of the six
viral parameters determined, as well as the approximate copy number of
viral DNA and mRNA per infected PMNL was calculated prior to (data
not reported) and after FACS purification following 1 and 3 h of
coculture (Table 4). After sorting, it
was found that the ratio of positive to negative (P/N) PMNLs for viral
DNA was 1/31.6 cells after 1 h and 1/7.1 cells after 3 h of
coculture, respectively, while at the same times the P/N ratios for
pp65 antigen were 1/242 and 1/19.6, and for IE mRNA 1/151 and
1/32.3, respectively, while the lowest P/N ratios were obtained for
infectious virus (1/5,000 and 1/625) and pp67 mRNA (1/16,666 and
1/3,125, respectively). In addition, the P/N ratio for p72 antigen was 1/497 after 1 h and 1/43 after 3 h of coculture. Results
obtained prior to cell sorting were fully comparable to those obtained after cell sorting. In particular, (i) the number of PMNLs positive for
each parameter consistently increased between 1- and 3-h coculture times; (ii) levels of nucleic acids in infected cells were about 3 log10 lower in PMNLs than in infected HUVEC for DNA and
pp67 mRNA, whereas they were only 1 log10 lower for IE
mRNA; (iii) the pp67 to IE mRNA copy number ratio, which was
15.2 in infected HUVEC for both copy number per infected cell and total
RNA amount per 105 cells, reached levels of 0.3 and 0.003 in 3-h-cocultured PMNLs, respectively; (iv) the maximal increase in
copy number per infected PMNL between 1- and 3-h coculture times was
relevant to IE mRNA. Comparable P/N results were obtained in an
AIDS patient with disseminated HCMV infection (data not shown).
View this table:
[in this window]
[in a new window]
|
TABLE 4.
HCMV load in VR6110-infected HUVEC at 96 h p.i. and
in PMNLs following 1 and 3 h of coculture and cell sorting
|
|
Blocking of HCMV transmission from PMNLs to uninfected HELF.
As previously shown for transfer of viral products from HCMV-infected
permissive cells to PMNLs (25), transmission of virus from
in vitro-generated HCMV-positive PMNLs to uninfected HELF was similarly
prevented or markedly reduced by either lack of contact between the two
cell populations or by incubation during coculture with either
anti-CD18 (72% reduction of infectious virus) or anti-ICAM-1 (86%
reduction) or both monoclonal antibodies (90 to 100% reduction).
Anti-E-selectin, anti-ICAM-3, and anti-PECAM-1 monoclonal antibodies
only reduced the level of infectious virus transmitted to PMNLs by 10 to 20%.
Fusion assays.
Labeling of VR6110-infected HUVEC with a green
fluorescent probe allowed tracing of PMNLs transiently fusing with
infected HUVEC. In addition, the rapid transfer to the nucleus of fused PMNLs of the green fluorescent probe according to a pattern resembling the pp65 antigen staining pattern suggested that the fluorescent probe
could be bound to pp65 (or some other protein with nuclear targeting).
Small dots of the green fluorescent probe were also infrequently
observed in the cytoplasm of PMNLs cocultured with infected HUVEC. No
fluorescent probe was observed in PMNLs cocultured with uninfected
HUVEC. A preliminary indication that pp65 could somehow mediate
migration of the fluorescent probe to the nucleus was supported by the
finding that in parallel experiments a comparable number of
pp65-positive PMNLs and PMNLs with fluorescent probe-labeled nuclei was
observed. In this respect, conclusive evidence that the same PMNL
nuclei were both chemically and immunologically labeled was provided by
the sequential staining of the same PMNLs with the fluorescent probe
and the pp65-specific monoclonal antibody pool, using either the
immunofluorescence or the immunoperoxidase technique (Fig.
4A to I).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 4.
Nuclear localization of the green fluorescent probe and
HCMV pp65 in the nuclei of PMNLs stained with the orange fluorescent
probe following coculture with VR6110-infected HUVEC stained with the
green fluorescent probe. The same PMNL nuclei stained by the green
fluorescent probe in panels A, C, E, and G are stained immunologically
(using a pp65-specific monoclonal antibody pool) by immunofluorescence
in panels B, D, and F and by immunoperoxidase in panel H. (I) PMNLs
stained with the orange fluorescent probe following coculture with
uninfected HUVEC stained with the green fluorescent probe.
|
|
Nuclear localization studies.
By using a polyclonal guinea pig
antiserum to HCMV able to stain pp65 and a mouse monoclonal antibody to
p72, we were able to show the nuclear localization in the same PMNLs of
the two HCMV proteins (Fig. 5C to H).
Patterns of staining were very different since pp65 stained the entire
nuclear area evenly (see Fig. 1 for comparison), although to a
different degree, whereas p72 was present as discrete brilliant dots
inside the nucleus (see Fig. 5A and B for comparison). However, p72
staining was weak or absent in PMNLs, whereas pp65 staining was strong.
Thus, the number of pp65-positive PMNLs was greater than the number of
p72-positive cells. Immunofluorescence laser confocal microscopy
confirmed the presence of p72 and pp65 in nuclei of the same PMNLs
(Fig. 5I to K).

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 5.
Detection of p72 and nuclear localization of p72 and
pp65 in PMNL nuclei. (A and B) Morphological patterns of p72 in PMNL
nuclei following overnight in vitro maintenance on HUVEC and 3 h
coculture with VR6110-infected HUVEC. Two examples of nuclear
localization of pp65 (C and E) and p72 (D and F) using sequential
double immunofluorescent staining (different fluorescent patterns),
sequential double immunostaining of pp65 (G) by immunoperoxidase and
p72 (H) by immunofluorescence, and simultaneous detection (I) of pp65
(J, rhodamine-labeled) and p72 (K, FITC-labeled) in a PMNL nucleus by
confocal microscopy are shown.
|
|
EM studies.
In order to investigate the morphological aspects
of the fusion of infected HUVEC and uninfected PMNLs and the transfer
of infected virus particles to PMNLs, cultures were fixed at different coculture times. Fusion events were apparently documented by
discontinuation of some tracts of the membranes of two adhering cells
with presence of a relatively small number of viral particles and dense
bodies, often unenveloped, in the cytoplasm of PMNLs (Fig.
6 and 7).
This finding was observed after 1, 3, and 24 h of coculture. In
addition, virus particles and dense bodies were observed within
vacuoles of endocytosis of PMNLs in a greater proportion with
increasing coculture times. The relatively low number of virus
particles detected by EM in a single PMNL following coculture appeared
to correlate somewhat with the relatively low viral DNA copy number per
PMNL.

View larger version (137K):
[in this window]
[in a new window]
|
FIG. 6.
Close contact and partial adhesion of a portion of a
VR6110-infected endothelial cell (lower right) and a portion of a PMNL
(upper left). The two inserts show, at a higher magnification, (a) a
cytoplasmic vacuole of the PMNL containing an enveloped virus particle
taken up by endocytosis (arrow) and (b) an unenveloped virus particle
in the context of the PMNL cytoplasm (arrow). Bars: left, 1 µm; right
(a and b), 100 nm.
|
|

View larger version (144K):
[in this window]
[in a new window]
|
FIG. 7.
Close interactions between a HCMV-infected endothelial
cell (upper right) and a PMNL (lower left). Several points of
discontinuation of the two adhering cell membranes are shown (see
arrows). Higher resolutions of the two cell membranes are shown in the
two inserts (a and b). Bars: left, 1 µm; right (a and b), 100 nm.
|
|
 |
DISCUSSION |
It is known that, unlike monocytes, PMNLs are not sites of HCMV
persistence in healthy individuals (31-33). Results of the present study indicate that infectious virus and late viral products are detected in PMNLs after 1 to 3 h of cocultivation with
HUVEC (or HELF) infected with a clinical HCMV strain. These
findings confirm previous data (19, 27) at much earlier
coculture times (1 to 3 h versus 16 to 24 h), and, together
with the results provided by the semiquantitation of IE and pp67
mRNAs, unequivocally document that virions and most viral material
detected in PMNLs after coculture are not the result of a complete
viral replication process occurring inside PMNLs, but are the result of
a direct transmission of previously assembled infectious virus and
synthesized viral material to PMNLs through a cell-to-cell contact
mechanism. This conclusion is supported by transfer to PMNLs of HUVEC
metabolites, such as VCAM-1 mRNAs, and fluorescent probes.
Full or abortive HCMV replication in PMNLs has been claimed by
different groups based upon detection of infectious virus and/or IE or
late viral transcripts, which were considered markers of active virus
replication inside PMNLs (1-3, 12, 16-18, 22-26, 35,
36). As an attempt to conclusively answer the question as to
whether HCMV replication does occur in PMNLs or not, we used RNA
and protein as well as viral DNA synthesis inhibitors during 3 h
of cocultivation and 3 h of migration. Results showed that only
HCMV IE gene transcription seems to occur inside PMNLs during 3 h
of coculture. This conclusion is based on the following: (i) 99%
reduction in IE mRNA (and not pp67 mRNA) levels in PMNLs following coculture in the presence of actinomycin D; (ii) the IE
mRNA is the only mRNA in infected PMNL approaching the levels observed in infected HUVEC (only about 1 log10 reduction);
(iii) the pp67 to IE mRNA copy number ratio, which is greater than
10 in HUVEC, becomes less than 1 in cocultured PMNLs; (iv) the IE mRNA is the only mRNA increasing in infected PMNL by about 1 log10 between 1 and 3 h coculture times among the
three nucleic acids measured. These data are supported by the
finding that viral DNA is distributed in comparable amounts between the
nucleus and cytoplasm of cocultured PMNLs, thus suggesting that
at least some virions entering PMNLs are uncoated and release viral
DNA, which enters the nucleus, initiating IE transcription.
Thus, viral material (infectious virus, viral DNA, and late viral
transcripts) detected in PMNLs at early coculture times (1 to 3 h)
is acquired by transfer from infected cells. Therefore, apart from IE
gene transcription, neither infectious virus nor late viral gene
products detected in PMNLs represent a marker of active virus
replication in these cells. The mechanism underlying the lack of
recovery of infectious virus from PMNLs cocultured with infected HUVEC,
following addition of actinomycin D either prior to, during, or after
coculture, while occurring in the presence of PFA, remains to be
clarified, but this mechanism seems to be related to a toxic effect of
the inhibitor on PMNLs.
How does transfer of virus and viral material to PMNLs occur? It was
previously shown that (i) lack of contact between infected HUVEC and
PMNLs prevents transfer of virus and viral material to PMNLs (19,
27); (ii) blocking of adhesion by monoclonal antibodies
anti-LFA-1 (CD18) and anti-ICAM-1 greatly reduced the number of
pp65-positive PMNLs, i.e., transfer of viral material to PMNLs
(27); and (iii) contact of PMNLs to infected cells was
transitory (27). In our study, all viral products uptaken by
PMNLs following incubation with infected cell culture medium were
considered to be acquired by endocytosis. In these experiments, pp65
was not found in PMNL nuclei and infectious virus could not be
recovered from PMNLs, thus indicating that virus uptaken by endocytosis
lost infectivity and that nuclear pp65 in PMNLs did not derive from
dense bodies uptaken by endocytosis. On the other hand, very small
amounts of viral nucleic acids (DNA, IE mRNA, and pp67 mRNA)
detected in PMNLs during endocytosis experiments were considered the
results of an uptake process. From these experiments, it clearly
appears that in PMNLs cocultured with HUVEC infected with clinical
isolates, 100% of pp65 antigen and infectious virus and more than 90%
of nucleic acids are derived from cell-to-cell transmission of virus
and viral products and not from endocytosis.
The mechanism by which transfer of viral material does occur was
investigated by EM and by using vital fluorescent probes. Several
tracts of discontinuation of the two adhering cell membranes were
observed by EM, with presence of dense bodies and of enveloped and
unenveloped virus particles in the PMNL cytoplasm. Since virus particles in vacuoles are most likely to be degraded, we considered virus particles present in the cytoplasm of cocultured PMNLs as potentially representing HCMV infectious virus. Similarly, we believe
that the newly synthesized pp65, prior to being assembled into
dense bodies, may travel through membrane discontinuation tracts, rapidly reaching PMNL nuclei driven by its nuclear
localization signals (9, 30), whereas pp65 sequestered
as dense bodies into endocytosis vacuoles is likely to be degraded.
Recently, abortive human immunodeficiency virus type 1 infection
of HUVEC has been rescued by T cells after coculture. The
mechanism has been attributed to a direct cell-to-cell contact followed
by fusion events consisting of discrete tracts of discontinuity between the adhering membranes of HUVEC and T cells (8). Cell
adhesion is mediated partially by interactions between ICAM-1 and
LFA-1, which have been considered a critical step in human
immunodeficiency virus type 1-mediated syncytia formation
(5).
However, the direct demonstration of the fusion of the two adhering
membranes was obtained by showing the appearance of a yellow-greenish
staining in PMNL nuclei, derived from the mixing of two vital
fluorescent dyes staining HUVEC (green) and PMNLs (orange),
respectively. In addition, it was shown that one of these fluorescent
probes was able to move rapidly to PMNL nuclei after coculture with
VR6110-infected cells. This property was hypothetically attributed to
the binding of the dye to a protein of infected cells with nuclear
targeting. This protein was likely to be the HCMV pp65 due to its
strong nuclear targeting in PMNLs (8, 28), its diffuse
nuclear localization in PMNLs along with the fluorescent probe staining
HCMV-infected HUVEC, and the overlapping number of pp65-positive and
fluorescent probe-labeled PMNL nuclei observed in parallel experiments.
This phenomenon was totally absent when laboratory-adapted HCMV strains
were used. In addition, it was shown that both pp65 and p72 localize in
the nucleus of the same PMNLs, thus confirming that different viral products entered the same cells.
In this study, no pp65-positive or infectious virus-positive PMNL was
found after coculture with HELF infected with HCMV AD169, Towne, or
Davis, thus confirming previously reported data (27). These
findings support the view that a genetic viral factor (now under
investigation) differentiates clinical and laboratory-adapted HCMV
strains. In addition, unlike clinical isolates, attenuated strains
AD169 and Towne were found to have a slower replication rate in thymic
stromal cells of SCID-hu mice (4) and to lack a large region
of DNA (6).
Furthermore, we investigated whether infectious virus transferred into
PMNLs after 1 to 3 h of coculture could further be transmitted to
susceptible HUVEC or HELF cells. It was found that transmission from
cocultured PMNLs to susceptible cells occurred, as it was already known
to occur for PMNLs from patients with disseminated HCMV infection
(15, 29, 37). In this study, transmission could be prevented
by lack of contact between the two cell populations and by the use of
monoclonal antibodies to CD18 or ICAM-1 or both but not by monoclonal
antibodies to E-selectin, PECAM-1, or ICAM-3. In this respect, it is
well known that HCMV recovery from ex vivo PMNL is successful only when
viable and nonsonicated cells are used, is improved by centrifuging
PMNL suspensions onto cell monolayers, and occurs in such a way that a
single HELF cell is infected by a single PMNL carrying infectious virus
(15). All these data support the need for a cell-to-cell contact for recovery of HCMV from infected PMNLs.
The copy number of nucleic acids per infected HUVEC was in the order of
104 to 105, while it was in the order of
101 to 102 in PMNLs after coculture. On this
basis, one can argue that active transfer must be mediated by very
rapid microfusion events. In addition, the number of cocultured PMNLs
positive for viral DNA approached 100% after 24 h of coculture
(data not reported), while it was high for pp65 and p72 antigens and
IE-mRNA and low for infectious virus and pp67 mRNAs. The
finding that the great majority or the totality of PMNLs become DNA
positive during a period of coculture of 24 h indicates that all
PMNLs come in contact with infected cells and receive a small amount of
infected material during such lag time.
Finally, the data reported in the present study indicate that HCMV
infectious virus, pp65 and p72 antigens, viral DNA, and IE and pp67
mRNAs in ex vivo PMNL preparations from immunocompromised patients
with disseminated infection are surrogate markers of HCMV infection and
cannot be considered as direct indicators of HCMV replication in vivo.
 |
ACKNOWLEDGMENTS |
We are indebted to Luca Dossena and Gabriella Garbagnoli for
excellent technical assistance. We thank Laura Salvaneschi for providing buffy coat preparations, Patrizia Vaghi for helping with
confocal microscopy, and Linda D'Arrigo for revision of the English.
We thank J. Middeldorp, Organon Teknika, for providing reagents for
NASBA determinations.
This work was partially supported by Ministero della Sanità,
Ricerca Finalizzata, grant no. 030RFM 98/01, by Istituto Superiore di
Sanità, II Programma Nazionale di Ricerca, sull'AIDS, grant no.
50B.21, and by Ricerca Corrente 1998, IRCCS Policlinico San Matteo.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Servizio di
Virologia, IRCCS Policlinico San Matteo, 27100 Pavia, Italy. Phone:
39-0382-502644/34. Fax: 39-0382-502599. E-mail:
g.gerna{at}smatteo.pv.it.
 |
REFERENCES |
| 1.
|
Bitsch, A.,
H. Kirchner,
R. Dupke, and G. Bein.
1993.
Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse-transcription-polymerase chain reaction.
J. Infect. Dis.
167:740-743[Medline].
|
| 2.
|
Blok, M. J.,
V. J. Goossens,
S. J. V. Vanherle,
B. Top,
N. Tacken,
J. M. Middeldorp,
M. H. L. Christiaans,
J. P. van Hooff, and C. A. Bruggeman.
1998.
Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograpt recipients by nucleic acid-sequence based amplification.
J. Clin. Microbiol.
36:1341-1346[Abstract/Free Full Text].
|
| 3.
|
Boivin, G.,
J. Handfield,
E. Toma,
R. Lalonde, and M. G. Bergeron.
1999.
Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma.
J. Infect. Dis.
179:1101-1107[CrossRef][Medline].
|
| 4.
|
Brown, J. M.,
H. Kaneshima, and E. S. Mocarski.
1995.
Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice.
J. Infect. Dis.
171:1599-1603[Medline].
|
| 5.
|
Butini, L.,
A. R. De Fougerolles,
M. Vaccarezza,
C. Graziosi,
D. I. Cohen,
M. Montroni,
T. A. Springer,
G. Pantaleo, and A. S. Fauci.
1994.
Intracellular adhesion molecules (ICAM)-1, ICAM-2, and ICAM-3 function as counter-receptor for lymphocyte function-associated molecule 1 in human immunodeficiency virus-mediated syncytia formation.
Eur. J. Immunol.
24:2191-2195[Medline].
|
| 6.
|
Cha, T.-H.,
E. Tom,
G. W. Kemble,
G. M. Duke,
E. S. Mocarski, and R. S. Spaete.
1996.
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.
J. Virol.
70:78-83[Abstract].
|
| 7.
|
Cybulsky, M. I.,
J. W. U. Fries,
A. J. Williams,
P. Sultan,
R. Eddy,
M. Byers,
T. Shows,
M. A. Gimbrone, Jr., and T. Collins.
1991.
Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene.
Proc. Natl. Acad. Sci. USA
88:7859-7863[Abstract/Free Full Text].
|
| 8.
|
Dianzani, F.,
O. Scheglovitova,
M. Gentile,
V. Scanio,
C. Barresi,
B. Ficociello,
F. Bianchi,
D. Fiumara, and M. R. Capobianchi.
1996.
Interferon gamma stimulates cell-mediated transmission of HIV tipe 1 from abortively infected endothelial cells.
AIDS Res. Hum. Retrovir.
12:621-627[Medline].
|
| 9.
|
Gallina, A.,
E. Percivalle,
L. Simoncini,
M. G. Revello,
G. Gerna, and G. Milanesi.
1996.
Human cytomegalovirus pp65 lower matrix phosphoprotein harbours two transplantable nuclear localization signals.
J. Gen. Virol.
77:1151-1157[Abstract/Free Full Text].
|
| 10.
|
Gerna, G.,
D. Zipeto,
E. Percivalle,
M. Parea,
M. G. Revello,
R. Maccario,
G. Peri, and G. Milanesi.
1992.
Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients.
J. Infect. Dis.
166:1236-1244[Medline].
|
| 11.
|
Gerna, G.,
E. Percivalle,
M. Torsellini, and M. G. Revello.
1998.
Standardization of the human cytomegalovirus antigenemia assay by means of in vitro generated pp65-positive peripheral blood polymorphonuclear leukocytes.
J. Clin. Microbiol.
36:3585-3589[Abstract/Free Full Text].
|
| 12.
|
Gerna, G.,
F. Baldanti,
J. M. Middeldorp,
M. Furione,
M. Zavattoni,
D. Lilleri, and M. G. Revello.
1999.
Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
J. Clin. Microbiol.
37:902-911[Abstract/Free Full Text].
|
| 13.
|
Gerna, G.,
M. Furione,
F. Baldanti, and A. Sarasini.
1994.
Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.
J. Clin. Microbiol.
32:2709-2717[Abstract/Free Full Text].
|
| 14.
|
Gerna, G.,
M. G. Revello,
E. Percivalle, and F. Morini.
1992.
Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.
J. Clin. Microbiol.
30:1232-1237[Abstract/Free Full Text].
|
| 15.
|
Gerna, G.,
M. G. Revello,
E. Percivalle,
M. Zavattoni,
M. Parea, and M. Battaglia.
1990.
Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.
J. Clin. Microbiol.
28:2681-2688[Abstract/Free Full Text].
|
| 16.
|
Gozlan, J.,
J. M. Salord,
C. Chouaïd,
C. Duvivier,
O. Picard,
M. C. Mejohas, and J. C. Petit.
1993.
Human cytomegalovirus (HCMV) late mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection.
J. Clin. Microbiol.
31:1943-1945[Abstract/Free Full Text].
|
| 17.
|
Gozlan, J.,
J. P. Laporte,
S. Lesage,
M. Labopin,
A. Najman,
N. C. Gorin, and J. C. Petit.
1996.
Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse trascription-PCR and blood and urine culture.
J. Clin. Microbiol.
34:2085-2088[Abstract].
|
| 18.
|
Grefte, A.,
M. C. Harmsen,
M. van der Giessen,
S. Knollema,
W. J. van Son, and T. H. The.
1994.
Presence of human cytomegalovirus (HCMV) immediate-early mRNA but not pp UL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection.
J. Gen. Virol.
75:1989-1998[Abstract/Free Full Text].
|
| 19.
|
Grundy, J. E.,
K. M. Lawson,
L. P. MacCormac,
J. M. Fletcher, and K. L. Yong.
1998.
Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration.
J. Infect. Dis.
177:1465-1474[Medline].
|
| 20.
|
Hession, K.,
R. Tizard,
C. Vassallo,
S. B. Schiffer,
D. Goff,
P. Moy,
G. Chi-Rosso,
S. Luhowski,
R. Lobb, and L. Osborn.
1991.
Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1).
J. Biol. Chem.
266:6682-6685[Abstract/Free Full Text].
|
| 21.
|
Jaroszeski, M. J.,
R. Gilbert, and R. Heller.
1994.
Detection and quantitation of cell-cell electrofusion products by flow cytometry.
Anal. Biochem.
216:271-275[CrossRef][Medline].
|
| 22.
|
Lam, K. M. C.,
N. Oldenburg,
M. A. Khan,
V. Gaylore,
G. W. Mikhail,
P. D. Stroual,
J. M. Middeldorp,
N. Banner, and M. Yacoub.
1998.
Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients.
J. Heart Lung Transplant
17:555-565[Medline].
|
| 23.
|
Meyer, T.,
U. Reischl,
H. Wolf,
C. Schuller, and R. Arndt.
1994.
Identification of active cytomegalovirus infection by analysis of immediate-early, early and late transcripts in peripheral blood cells of immunodeficient patients.
Mol. Cell. Probes
8:261-271[CrossRef][Medline].
|
| 24.
|
Meyer-König, U.,
A. Serr,
D. van Laer,
G. Kirste,
C. Wolff,
O. Haller,
D. Neuman-Haefelin, and F. T. Hufert.
1995.
Human cytomegalovirus immediate-early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients.
J. Infect. Dis.
171:705-709[Medline].
|
| 25.
|
Nelson, P. N.,
B. K. Kawal,
Y. S. Boriskin,
K. E. Mathers,
R. L. Powles,
H. M. Steel,
Y. S. Tryhorn,
P. D. Butcther, and J. C. Booth.
1996.
A polymerase chain reaction to detect a spliced late transcript of human cytomegalovirus in the blood of bone marrow transplant recipients.
J. Virol. Methods
56:139-148[CrossRef][Medline].
|
| 26.
|
Randhawa, P. S.,
R. Manez,
B. Frye, and G. D. Ehrlich.
1994.
Circulating immediate-early mRNA in patients with cytomegalovirus infections after solid organ transplantation.
J. Infect. Dis.
170:1264-1267[Medline].
|
| 27.
|
Revello, M. G.,
E. Percivalle,
E. Arbustini,
R. Pardi,
S. Sozzani, and G. Gerna.
1998.
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.
J. Clin. Investig.
101:2686-2692[Medline].
|
| 28.
|
Revello, M. G.,
E. Percivalle,
M. Zavattoni,
M. Parea,
P. Grossi, and G. Gerna.
1989.
Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients.
J. Med. Virol.
29:88-93[Medline].
|
| 29.
|
Saltzmann, R. L.,
M. R. Quirk, and M. C. Jordan.
1988.
Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.
J. Clin. Investig.
81:75-81.
|
| 30.
|
Schmolke, S.,
P. Drescher,
G. Jahn, and B. Plachter.
1995.
Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport.
J. Virol.
69:1071-1078[Abstract].
|
| 31.
|
Stanier, P.,
D. L. Taylor,
A. D. Kitchen,
N. Wales,
Y. Tryhorn, and A. S. Tyms.
1989.
Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors.
Br. Med. J.
299:897-898.
|
| 32.
|
Taylor-Wiedeman, J.,
G. P. Hayhurst,
J. G. P. Sissons, and J. H. Sinclair.
1993.
Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals.
J. Gen. Virol.
74:265-268[Abstract/Free Full Text].
|
| 33.
|
Taylor-Wiedeman, J.,
J. G. P. Sissons,
L. K. Borysiewicz, and J. H. Sinclair.
1991.
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells.
J. Gen. Virol.
72:2059-2064[Abstract/Free Full Text].
|
| 34.
|
van der Bij, W.,
J. Schirm,
R. Torensma,
W. J. van Son,
A. M. Tegzess, and T. H. The.
1988.
Comparison between viremia and antigenemia for detection of cytomegalovirus in blood.
J. Clin. Microbiol.
26:2531-2535[Abstract/Free Full Text].
|
| 35.
|
Velzing, J.,
P. H. Rothbarth,
A. C. M. Kroes, and W. G. V. Quint.
1994.
Detection of cytomegalovirus mRNA and DNA encoding the immediate-early gene in peripheral blood leukocytes from immunocompromised patients.
J. Med. Virol.
42:164-169[Medline].
|
| 36.
|
von Laer, D.,
A. Serr,
U. Meyer-König,
G. Kirste,
F. T. Hufert, and O. Haller.
1995.
Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo.
J. Infect. Dis.
172:365-370[Medline].
|
| 37.
|
Zaia, J. A.,
S. J. Forman,
M. T. Gallagher,
E. Vanderwal-Urbina, and K. G. Blume.
1984.
Prolonged human cytomegalovirus viremia following bone marrow transplantation.
Transplantation
37:315-317[Medline].
|
Journal of Virology, June 2000, p. 5629-5638, Vol. 74, No. 12
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Shaik, S. S., Soltau, T. D., Chaturvedi, G., Totapally, B., Hagood, J. S., Andrews, W. W., Athar, M., Voitenok, N. N., Killingsworth, C. R., Patel, R. P., Fallon, M. B., Maheshwari, A.
(2009). Low Intensity Shear Stress Increases Endothelial ELR+ CXC Chemokine Production via a Focal Adhesion Kinase-p38{beta} MAPK-NF-{kappa}B Pathway. J. Biol. Chem.
284: 5945-5955
[Abstract]
[Full Text]
-
Schroer, J., Shenk, T.
(2008). Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc. Natl. Acad. Sci. USA
105: 19468-19473
[Abstract]
[Full Text]
-
Gerna, G., Lilleri, D., Locatelli, F.
(2008). Response: Human cytomegalovirus DNAemia and preemptive treatment of HCMV infection in children receiving hematopoietic stem-cell transplantation. Blood
111: 4420-4420
[Full Text]
-
Gerna, G., Sarasini, A., Patrone, M., Percivalle, E., Fiorina, L., Campanini, G., Gallina, A., Baldanti, F., Revello, M. G.
(2008). Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J. Gen. Virol.
89: 853-865
[Abstract]
[Full Text]
-
Goodrum, F., Reeves, M., Sinclair, J., High, K., Shenk, T.
(2007). Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood
110: 937-945
[Abstract]
[Full Text]
-
Maidji, E., Genbacev, O., Chang, H.-T., Pereira, L.
(2007). Developmental Regulation of Human Cytomegalovirus Receptors in Cytotrophoblasts Correlates with Distinct Replication Sites in the Placenta. J. Virol.
81: 4701-4712
[Abstract]
[Full Text]
-
Gattegno, T., Mittal, A., Valansi, C., Nguyen, K. C.Q., Hall, D. H., Chernomordik, L. V., Podbilewicz, B.
(2007). Genetic Control of Fusion Pore Expansion in the Epidermis of Caenorhabditis elegans. Mol. Biol. Cell
18: 1153-1166
[Abstract]
[Full Text]
-
Bentz, G. L., Jarquin-Pardo, M., Chan, G., Smith, M. S., Sinzger, C., Yurochko, A. D.
(2006). Human Cytomegalovirus (HCMV) Infection of Endothelial Cells Promotes Naive Monocyte Extravasation and Transfer of Productive Virus To Enhance Hematogenous Dissemination of HCMV. J. Virol.
80: 11539-11555
[Abstract]
[Full Text]
-
Boehme, K. W., Guerrero, M., Compton, T.
(2006). Human Cytomegalovirus Envelope Glycoproteins B and H Are Necessary for TLR2 Activation in Permissive Cells. J. Immunol.
177: 7094-7102
[Abstract]
[Full Text]
-
Sinzger, C., Eberhardt, K., Cavignac, Y., Weinstock, C., Kessler, T., Jahn, G., Davignon, J.-L.
(2006). Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules. J. Gen. Virol.
87: 1853-1862
[Abstract]
[Full Text]
-
Wang, D., Shenk, T.
(2005). Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. USA
102: 18153-18158
[Abstract]
[Full Text]
-
Patrone, M., Secchi, M., Fiorina, L., Ierardi, M., Milanesi, G., Gallina, A.
(2005). Human Cytomegalovirus UL130 Protein Promotes Endothelial Cell Infection through a Producer Cell Modification of the Virion. J. Virol.
79: 8361-8373
[Abstract]
[Full Text]
-
Kinzler, E. R., Compton, T.
(2005). Characterization of Human Cytomegalovirus Glycoprotein-Induced Cell-Cell Fusion. J. Virol.
79: 7827-7837
[Abstract]
[Full Text]
-
Gerna, G., Percivalle, E., Lilleri, D., Lozza, L., Fornara, C., Hahn, G., Baldanti, F., Revello, M. G.
(2005). Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J. Gen. Virol.
86: 275-284
[Abstract]
[Full Text]
-
Hahn, G., Revello, M. G., Patrone, M., Percivalle, E., Campanini, G., Sarasini, A., Wagner, M., Gallina, A., Milanesi, G., Koszinowski, U., Baldanti, F., Gerna, G.
(2004). Human Cytomegalovirus UL131-128 Genes Are Indispensable for Virus Growth in Endothelial Cells and Virus Transfer to Leukocytes. J. Virol.
78: 10023-10033
[Abstract]
[Full Text]
-
Nerheim, P. L., Meier, J. L., Vasef, M. A., Li, W.-G., Hu, L., Rice, J. B., Gavrila, D., Richenbacher, W. E., Weintraub, N. L.
(2004). Enhanced Cytomegalovirus Infection in Atherosclerotic Human Blood Vessels. Am. J. Pathol.
164: 589-600
[Abstract]
[Full Text]
-
Patrone, M., Percivalle, E., Secchi, M., Fiorina, L., Pedrali-Noy, G., Zoppe, M., Baldanti, F., Hahn, G., Koszinowski, U. H., Milanesi, G., Gallina, A.
(2003). The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection. J. Gen. Virol.
84: 3359-3370
[Abstract]
[Full Text]
-
van der Strate, B. W. A., Hillebrands, J. L., Lycklama a Nijeholt, S. S., Beljaars, L., Bruggeman, C. A., van Luyn, M. J. A., Rozing, J., The, T. H., Meijer, D. K. F., Molema, G., Harmsen, M. C.
(2003). Dissemination of Rat Cytomegalovirus through Infected Granulocytes and Monocytes In Vitro and In Vivo. J. Virol.
77: 11274-11278
[Abstract]
[Full Text]
-
Gerna, G., Lilleri, D., Baldanti, F., Torsellini, M., Giorgiani, G., Zecca, M., De Stefano, P., Middeldorp, J., Locatelli, F., Revello, M. G.
(2003). Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. Blood
101: 5053-5060
[Abstract]
[Full Text]
-
Gerna, G., Percivalle, E., Sarasini, A., Baldanti, F., Campanini, G., Revello, M. G.
(2003). Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells. J. Gen. Virol.
84: 1431-1436
[Abstract]
[Full Text]
-
Van de Walle, G. R., Favoreel, H. W., Nauwynck, H. J., Mettenleiter, T. C., Pensaert, M. B.
(2003). Transmission of pseudorabies virus from immune-masked blood monocytes to endothelial cells. J. Gen. Virol.
84: 629-637
[Abstract]
[Full Text]
-
Kronschnabl, M., Stamminger, T.
(2003). Synergistic induction of intercellular adhesion molecule-1 by the human cytomegalovirus transactivators IE2p86 and pp71 is mediated via an Sp1-binding site. J. Gen. Virol.
84: 61-73
[Abstract]
[Full Text]
-
Boom, R., Sol, C. J. A., Schuurman, T., van Breda, A., Weel, J. F. L., Beld, M., ten Berge, I. J. M., Wertheim-van Dillen, P. M. E, de Jong, M. D.
(2002). Human Cytomegalovirus DNA in Plasma and Serum Specimens of Renal Transplant Recipients Is Highly Fragmented. J. Clin. Microbiol.
40: 4105-4113
[Abstract]
[Full Text]
-
Revello, M. G., Gerna, G.
(2002). Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant. Clin. Microbiol. Rev.
15: 680-715
[Abstract]
[Full Text]
-
Gerna, G., Percivalle, E., Sarasini, A., Baldanti, F., Revello, M. G.
(2002). The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko- (neutrophil- and monocyte-) tropism in vitro. J. Gen. Virol.
83: 1993-2000
[Abstract]
[Full Text]
-
Gerna, G., Percivalle, E., Sarasini, A., Revello, M. G.
(2002). Human Cytomegalovirus and Human Umbilical Vein Endothelial Cells: Restriction of Primary Isolation to Blood Samples and Susceptibilities of Clinical Isolates from Other Sources to Adaptation. J. Clin. Microbiol.
40: 233-238
[Abstract]
[Full Text]
-
Grazia Revello, M., Baldanti, F., Percivalle, E., Sarasini, A., De-Giuli, L., Genini, E., Lilleri, D., Labò, N., Gerna, G.
(2001). In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J. Gen. Virol.
82: 1429-1438
[Abstract]
[Full Text]
-
Tabi, Z., Moutaftsi, M., Borysiewicz, L. K.
(2001). Human Cytomegalovirus pp65- and Immediate Early 1 Antigen-Specific HLA Class I-Restricted Cytotoxic T Cell Responses Induced by Cross-Presentation of Viral Antigens. J. Immunol.
166: 5695-5703
[Abstract]
[Full Text]
-
Greijer, A. E., Verschuuren, E. A. M., Harmsen, M. C., Dekkers, C. A. J., Adriaanse, H. M. A., The, T. H., Middeldorp, J. M.
(2001). Direct Quantification of Human Cytomegalovirus Immediate-Early and Late mRNA Levels in Blood of Lung Transplant Recipients by Competitive Nucleic Acid Sequence-Based Amplification. J. Clin. Microbiol.
39: 251-259
[Abstract]
[Full Text]